Immune Checkpoint Inhibitors Intrathecal Injection in Patients With Leptomeningeal Metastases in NSCLC
Conditions: NSCLC Associated With Leptomeningeal Metastases Interventions: Drug: Tislelizumab, pemetrexed Sponsors: West China Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alimta | China Health | Hospitals | Neoplastic Meningitis | Non-Small Cell Lung Cancer | Research